The key finding
Scientists have identified a group of molecules called trace amines—including tyramine, β-phenylethylamine, and octopamine—that function as neurotransmitters in the brain, acting through specialized receptors called TAARs (trace amine-associated receptors). These substances are linked to regulation of mood, movement, cognition, and even the birth of new brain cells in adults. Disrupted trace amine signaling has been associated with several neuropsychiatric conditions including schizophrenia, Parkinson’s disease, addiction, depression, and anxiety. Researchers are now using zebrafish as a translational model to understand how these little-known brain chemicals influence behavior and brain function.
What the study looked like
This 2025 review synthesizes research on trace amine biology, focusing particularly on studies using zebrafish (Danio rerio) as experimental models. The authors examined how trace amines and their receptors are distributed across different brain regions and how they interact with other neurotransmitter systems, particularly dopamine and serotonin pathways. The review integrates findings from rodent genetic and pharmacological studies with emerging zebrafish research, examining both how trace amines are naturally expressed in the brain and how experimental manipulation of TAAR signaling affects behavior. Zebrafish offer advantages as a model system because their transparent embryos allow researchers to observe brain development in real time, they reproduce quickly, and their genetic makeup can be easily modified to study specific receptor functions.
Why researchers think this happened
Trace amines were long considered metabolic byproducts rather than active signaling molecules, but the discovery of TAARs—a family of G protein-coupled receptors specifically activated by these compounds—revealed their neurotransmitter role. Researchers propose that trace amines modulate the activity of classical neurotransmitter systems, particularly dopamine and serotonin, rather than working independently. This modulatory function may explain why disrupted TAAR signaling appears in multiple psychiatric conditions: altered trace amine activity could tip the balance of dopamine or serotonin transmission in ways that contribute to symptoms. The link to adult neurogenesis—the birth of new neurons in the mature brain—suggests trace amines may also play roles in brain plasticity and adaptation. Prior work in rodents demonstrated these connections, and zebrafish models are now allowing researchers to visualize these processes more directly and test interventions more rapidly than traditional mammalian models permit.
How to read this carefully
This is a review article synthesizing existing research rather than presenting new experimental data, so conclusions depend on the quality of underlying studies. The associations between trace amine disruption and psychiatric disorders come largely from correlational evidence—we cannot yet say that TAAR dysfunction causes these conditions, only that the two appear linked. Much of the mechanistic understanding comes from animal models, particularly rodents and zebrafish, which may not perfectly translate to human brain function. Zebrafish, while valuable for genetic manipulation and observation, have significant neurological differences from mammals. The field is relatively young—TAARs were only identified in the early 2000s—meaning many proposed mechanisms await confirmation through replication and more detailed study.
What this means for everyday life
Understanding trace amine signaling could eventually inform new treatment approaches for conditions like depression, anxiety, or movement disorders, though such applications remain in early research stages. Some trace amines like tyramine are present in aged cheeses, fermented foods, and certain beverages, which is why people taking older antidepressants (MAO inhibitors) must avoid these foods—though this dietary concern relates to peripheral effects rather than brain TAAR signaling. For now, the most practical takeaway is that brain chemistry involves far more players than the well-known neurotransmitters like serotonin and dopamine. The complexity of these interacting systems reminds us why psychiatric conditions rarely have simple causes or one-size-fits-all treatments. As research progresses, trace amine pathways may become targets for more precisely tailored interventions.